Clinical Trial Update: Kappa Opioid Receptor Imaging in Depression (KOR Depression)

View source ↗

Summary

A clinical trial investigating kappa opioid receptor imaging in major depressive disorder and anhedonia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anhedonia
• Major Depressive Disorder

Snippet

Sponsor: NYU Langone Health | Conditions: Major Depressive Disorder, Anhedonia | Status: TERMINATED